Signaling pathways
-
BA7735 MK-0941Summary: MK-0941 is a potent, orally available allosteric activator of glucokinase. - BA7736 AZD1656Summary: AZD1656 is a potent, selective, orally active glucokinase activator.
- BA7737 AMG-3969Summary: AMG-3969 is a potent disruptor of glucokinase-glucokinase regulatory protein interactions.
- BA7738 CadisegliatinSummary: Cadisegliatin (TTP-399) is a potential liver-selective glucokinase activator with oral activity.
- BA7739 PF-04991532Summary: PF-04991532 is a potent hepatic-selective glucokinase activator.
- BA7740 AM-2394Summary: AM-2394 is a novel activator (GKA).
- BA7741 AR453588Summary: AR453588 is a potent orally bioavailable antidiabetic glucokinase activator.
- BA7742 BMS-820132Summary: BMS-820132 is an orally effective, partial glucokinase activator.
- BA7743 IHVR-11029Summary: IHVR-11029 is an inhibitor.
- BA7744 AMG-1694Summary: AMG-1694 is a potent glucokinase-glucokinase regulatory protein disruptor.